What is the recommended epinephrine dosage for cardiac arrest in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Epinephrine Dosage for Cardiac Arrest

For adults in cardiac arrest, administer 1 mg of epinephrine (1:10,000 solution) IV/IO every 3-5 minutes; for children, administer 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) IV/IO every 3-5 minutes, with a maximum single dose of 1 mg. 1, 2

Adult Dosing

The 2025 American Heart Association guidelines maintain the standard dose of 1 mg epinephrine IV/IO every 3-5 minutes for all cardiac arrest rhythms 2. This represents the most current evidence-based recommendation. Operationally, this means administering epinephrine every second cycle of CPR after the initial dose 1.

Timing Considerations

  • Shockable rhythms (VF/pVT): Administer epinephrine after initial CPR and defibrillation attempts are unsuccessful—prioritize rapid defibrillation first 2
  • Non-shockable rhythms (asystole/PEA): Administer epinephrine as soon as feasible once vascular access is obtained 1, 2

High-Dose Epinephrine: Not Recommended

High-dose epinephrine (0.1-0.2 mg/kg) is NOT recommended for routine use 1. Multiple studies demonstrate no survival benefit and potential harm, particularly in asphyxial arrest 1. The only exception is β-blocker overdose, where high-dose epinephrine may be considered 1.

Pediatric Dosing

Standard dose: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) IV/IO every 3-5 minutes, maximum 1 mg per dose 1

Concentration-Specific Dosing

  • IV/IO route: 0.01 mg/kg using 1:10,000 solution (0.1 mg/mL)
  • Endotracheal route (if IV/IO unavailable): 0.1 mg/kg using 1:1,000 solution (1 mg/mL)—this is 10 times the IV dose 1, 3, 1

Newborn-Specific Dosing

For newborn infants during cardiopulmonary resuscitation:

  • IV/IO: 0.01-0.03 mg/kg of 1:10,000 solution
  • Endotracheal: 0.03-0.10 mg/kg of 1:10,000 solution 3

Critical Administration Details

Route Priority

  1. IV access preferred (large vein when possible)
  2. IO access if IV unsuccessful or delayed
  3. Endotracheal route only as last resort—requires higher doses and has inferior bioavailability 1, 4

Common Pitfalls to Avoid

Concentration confusion is dangerous: Epinephrine comes in two concentrations:

  • 1:10,000 (0.1 mg/mL) for IV/IO cardiac arrest dosing
  • 1:1,000 (1 mg/mL) for endotracheal dosing or anaphylaxis IM dosing

Using the wrong concentration can result in 10-fold dosing errors 3.

Endotracheal Administration Caveats

When giving epinephrine via endotracheal tube:

  • Flush with at least 5 mL normal saline
  • Follow with 5 consecutive positive-pressure ventilations 1
  • Expect lower and delayed peak concentrations compared to IV/IO routes 4
  • Evidence suggests endotracheal epinephrine may be less effective than vascular administration 1

Special Circumstance: Anaphylaxis-Induced Cardiac Arrest

For cardiac arrest specifically from anaphylaxis, guidelines suggest higher initial doses and more aggressive escalation 5:

Adults:

  • Initial: 1-3 mg IV (1:10,000) over 3 minutes
  • Second: 3-5 mg IV over 3 minutes
  • Then: 4-10 mg/min infusion 5

Children:

  • Initial: 0.01 mg/kg (0.1 mL/kg of 1:10,000) every 3-5 minutes
  • Consider higher doses (0.1-0.2 mg/kg of 1:1,000) for unresponsive asystole/PEA 5

Standard IM anaphylaxis dosing (0.3-0.5 mg) is insufficient for cardiac arrest from anaphylaxis—IV/IO dosing at cardiac arrest doses is required 4.

Evidence Quality and Rationale

The recommendation for standard-dose epinephrine is based on consistent evidence showing improved return of spontaneous circulation (ROSC) and survival to hospital admission 2. However, a critical limitation exists: epinephrine does not improve survival with favorable neurologic outcome 2, 6. Despite this, epinephrine remains standard therapy because short-term survival is a prerequisite for any meaningful recovery, and no alternative has proven superior 2.

The 2010 AHA Pediatric Advanced Life Support guidelines 1 remain the most comprehensive pediatric-specific guidance, with consistent recommendations maintained through 2025 7. The evidence against high-dose epinephrine in children is particularly strong, showing potential harm especially in asphyxial arrest 1.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.